Acute Promyelocytic Leukemia in a Woman with Thalassemia Intermedia: Case Report and Review of Literature on Hematological Malignancies in β-Thalassemia Patients
- PMID: 36278522
- PMCID: PMC9590045
- DOI: 10.3390/hematolrep14040045
Acute Promyelocytic Leukemia in a Woman with Thalassemia Intermedia: Case Report and Review of Literature on Hematological Malignancies in β-Thalassemia Patients
Abstract
Patients affected by transfusion-dependent β-thalassemia are prone to developing several clinical complications, mostly related to the iron overload. We report the case of a patient affected by transfusion-dependent β-thalassemia (TDT) developing acute promyelocytic leukemia (APL). In our case, the therapeutic management was significantly complicated not only by myocardial dysfunction, but also by the occurrence of the differentiation syndrome following all-trans retinoic acid (ATRA) administration. We carried out a careful revision of the current literature on the occurrence of hematological malignancies in β-thalassemia patients to investigate the major complications so far described. APL occurrence in β-thalassemia patients has been very rarely reported, and our experience suggests that TDT patients suffering pre-existing comorbidities may develop a potentially fatal complication during ATRA therapy.
Keywords: ATRA differentiation syndrome; acute promyelocytic leukemia; hematological malignancies; retinoic acid; β-thalassemia.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
A rare case of perimyocarditis induced by all-trans retinoic acid administration during induction treatment of acute promyelocytic leukemia.Med Pharm Rep. 2019 Oct;92(4):418-420. doi: 10.15386/mpr-1229. Epub 2019 Oct 25. Med Pharm Rep. 2019. PMID: 31750445 Free PMC article.
-
All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.Semin Hematol. 1994 Oct;31(4 Suppl 5):38-48. Semin Hematol. 1994. PMID: 7831584 Review.
-
[Acute promyelocytic leukemia: state-of-the-art management].Rinsho Ketsueki. 2018;59(6):725-734. doi: 10.11406/rinketsu.59.725. Rinsho Ketsueki. 2018. PMID: 29973452 Review. Japanese.
-
Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.Cardiooncology. 2021 Nov 23;7(1):39. doi: 10.1186/s40959-021-00124-9. Cardiooncology. 2021. PMID: 34814948 Free PMC article.
-
All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review.Case Rep Oncol Med. 2012;2012:313057. doi: 10.1155/2012/313057. Epub 2012 Jun 3. Case Rep Oncol Med. 2012. PMID: 22701192 Free PMC article.
Cited by
-
Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives.Front Immunol. 2024 Aug 5;15:1403458. doi: 10.3389/fimmu.2024.1403458. eCollection 2024. Front Immunol. 2024. PMID: 39161767 Free PMC article. Review.
-
Genome-wide methylation and gene-expression analyses in thalassemia.Aging (Albany NY). 2024 Aug 9;16(15):11591-11605. doi: 10.18632/aging.206037. Epub 2024 Aug 9. Aging (Albany NY). 2024. PMID: 39133159 Free PMC article.
References
-
- Taher A.T., Cappellini M.D. How I manage medical complications of b-thalassemia in adults. [(accessed on 18 May 2022)];Blood. 2018 132:1781–1791. doi: 10.1182/blood-2018-06-818187. Available online: http://ashpublications.org/blood/article-pdf/132/17/1781/1468099/blood81.... - DOI - PubMed
-
- Mufti G.J., Bennett J.M., Goasguen J., Bain B.J., Baumann I., Brunning R., Cazzola M., Fenaux P., Germing U., Hellström-Lindberg E. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. [(accessed on 18 May 2022)];Haematologica. 2008 93:1712–1717. doi: 10.3324/haematol.13405. Available online: https://haematologica.org/article/view/5076. - DOI - PubMed
-
- Sanz M.A., Fenaux P., Tallman M.S., Estey E.H., Löwenberg B., Naoe T., Lengfelder E., Döhner H., Burnett A.K., Chen S.-J., et al. Management of acute promyelocytic leukemia: Updated recommendations from an expert panel of the European LeukemiaNet. [(accessed on 18 May 2022)];Blood. 2019 133:1630–1643. doi: 10.1182/blood-2019-01-894980. Available online: https://pubmed.ncbi.nlm.nih.gov/30803991/ - DOI - PMC - PubMed
-
- Lo-Coco F., Avvisati G., Vignetti M., Breccia M., Gallo E., Rambaldi A., Paoloni F., Fioritoni G., Ferrara F., Specchia G., et al. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: Results of the AIDA-2000 trial of the GIMEMA Group. Blood. 2010;116:3171–3179. doi: 10.1182/blood-2010-03-276196. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources